Benzinga | Nov 9, 2021 11:09AM EST

ORIC Pharmaceuticals Q3 EPS $(0.47) Up From $(0.84) YoY

ORIC Pharmaceuticals (NASDAQ:ORIC) reported quarterly losses of $(0.47) per share. This is a 44.05 percent increase over losses of $(0.84) per share from the same period last year.